ArticleCost effectiveness and resource allocation : C/E2021
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.
Article in Cost effectiveness and resource allocation : C/E, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 19 citations in OpenAlex.
- The role of economic evaluation in public health emergency management of disease outbreaks in Africa: a qualitative research.Health economics review · 2026Article
- What is the Value of Developing an HTA Process?PharmacoEconomics · 2026Review
- Unlocking the Potential of Health Technology Assessment (HTA) in Indonesian Midwifery: Challenges and Opportunities.Health science reports · 2026Article
- Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy.Journal of market access & health policy · 2026Article
- Innovating HTA: a call for capacity building and standardization.International journal of technology assessment in health care · 2026Review
- Health technology reassessment and disinvestment instruments: a scoping review.Health research policy and systems · 2026Review
- Article
- A case study integrating scenario thinking with dialysis policymaking in Thailand.Communications medicine · 2025Article
- Mapping the social networks of key actors in the development of health technology assessment in Iran.Journal of preventive medicine and hygiene · 2025Article
- How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective.International journal of technology assessment in health care · 2025Review
- Propensity score matching for comparative studies: a tutorial with R and Rex.Journal of minimally invasive surgery · 2024Review
- Economic Rationality in Decision-Making Regarding Newborn Screening: A Case Study in Quebec.International journal of neonatal screening · 2024Article
- A situational and stakeholder analysis of health technology assessment in Zimbabwe.International journal of technology assessment in health care · 2024Article
- The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum.International journal of technology assessment in health care · 2023Article
- Health technology assessment implementation in WHO South-East Asia Region: a realist review protocol.Wellcome open research · 2023Article
- What is the value of explicit priority setting for health interventions? A simulation study.Health care management science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 5 countries.
Funding
Abstract
backgroundHealth technology assessment (HTA) agencies have an important role to play in managing the rising demands on health systems. However, creating and running such agencies potentially diverts resources from frontline services. A large number of studies address the question of 'what is the impact of HTA?'. Several points of heterogeneity in this literature include: purpose of the study, definition of HTA, definition of impact, and scope and rigour of evaluations. Our study seeks to address several limitations in this literature. This study aims to explore the mechanisms of impact of an HTA agency. In doing so, we consider HTA as an institution rather than a knowledge product to build an impact evaluation framework from an international, multi-stakeholder and multi-dimensional perspective.
methodsWe conducted 9 key informant interviews with experts from the international HTA community. We addressed several questions, informed by existing frameworks of impact within the literature, to understand their perspectives on the mechanisms of impact of an HTA agency. We analyse data using logic modelling and impact mapping, as tools to understand and visualise mechanisms of change.
findingsOur impact mapping highlights several distinct, but not necessarily mutually exclusive, mechanisms through which the overall impact of an HTA agency is achieved. These are: the effective conduct of HTA studies; effective use of HTA in agenda-setting and policy formulation processes; effective engagement and external communications; good institutional reputation and fit within the healthcare and policy-making system; effective use of HTA as a tool for the negotiation of health technology prices; and the effective implementation of policy change regarding health technologies. We also identify indicators of these effects.
conclusionsOur findings and resulting evaluation framework complement and add to existing literature by offering a new perspective on the mechanisms by which HTA agencies generate impact. This new perspective considers HTA as an institution rather than a knowledge product, is international, multi-dimensional, and includes multi-stakeholder views. We hope the analysis will be useful to countries interested in managing HTA performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.